← Back to front page
Oceania · News · The Mercury

Argent BioPharma sets four priorities as it eyes healthy ageing research

Published by The Mercury · Australia 12 h ago

Argent BioPharma (ASX:RGT) has listed four strategic priorities following the global licensing of CannEpil, expansion of its pharmaceutical development programs and continued…

Read the full article on The Mercury Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.themercury.com.au)

Also worth reading

PerthNow

'Extreme' sect reported years before young girl's death

 Brisbane Times

King River goes deep with 11,000m WA Murchison gold assault

 The Conversation AU

This economist believes the system is broken. Maybe she has a point

 The Age

Senior police officer facing sack over claims of rough, non-consensual sex

 WAtoday

Senior police officer facing sack over claims of rough, non-consensual sex

 The Canberra Times

The words that should haunt Canberrans in the wake of this awful sentencing